Workflow
全链条产业生态
icon
Search documents
“全链条”+“统一运营”聚合优势助企腾飞
Xin Lang Cai Jing· 2025-12-20 14:59
集群化、园区化发展是汕头纺织服装产业破解"散小弱"困境,在日益激烈的市场竞争中突围的关键一招。中国家居服专业采购基地通过"全链条"产业生态 构建和"统一运营"管理模式创新,正成为推动汕头纺织服装产业集群高质量发展的重要平台,为区域经济转型升级提供有力支撑。 潮南作为全国家居服产业的核心集聚区,已形成从面料织造、染整、辅料供应到成品生产、销售的完整产业链,现有纺织服装市场主体超过8800家,家居 服产量更是占据全国市场近八成份额。然而生产企业布局分散,大多数企业规模小且集聚化程度不高成为制约产业发展的关键瓶颈。在党委政府的正确引 导和产业企业共同呼吁下,中国家居服专业采购基地作为破题之举应运而生。 "基地把上下游企业整合在一起,对成衣制造来说太实用了。我们再也不用跨区域采购面辅料,家门口就能选到优质货源,省时省力更省钱。遇到问题能 当场和供应商沟通调整,生产周期缩短,交付效率大大提升。"汕头市丰琳服饰有限公司总经理林燕卿说。 基地以"生产、办公、生活、商务"四位一体为核心,构建起覆盖企业从初创到壮大全生命周期的功能体系,让企业"足不出园"即可满足所有运营需求。在 产业配套方面,基地规划建设智能化工业园区;家居服 ...
体制创新驱动 湘潭医疗器械产业蝶变
Core Insights - Hunan Xiangtan is transforming from a traditional Chinese medicine distribution center to a leading hub for medical device innovation in China, with a projected total output value exceeding 13 billion yuan by 2024 [1][5] Group 1: Industry Development - The Hunan Medical Device Industrial Park has been recognized as a national benchmark for medical device industrial parks for two consecutive years, showcasing successful integration of technological and industrial innovation [1][5] - The park has established a unique "4+N" service system that integrates government support with market effectiveness, addressing common industry challenges such as slow approval processes and intellectual property conversion [2] Group 2: Approval Process Innovation - The establishment of the Hunan Provincial Drug Supervision Administration's Xiangtan branch has significantly improved the efficiency of product registration and approval, allowing companies to bring products to market faster [2] - Companies like Hunan Depus Medical Technology Co., Ltd. have experienced expedited approval processes, receiving registration certificates in as little as one month compared to the typical six months [2] Group 3: Corporate Innovation - The Hunan Medical Device Industrial Park focuses on meeting corporate needs, creating a comprehensive industrial ecosystem that includes concept validation, clinical trials, and logistics [3] - Companies such as Huaxin Medical are gaining a foothold in the global market, with their products being exported to over 160 countries and achieving a leading market share in disposable bronchoscopes [3] Group 4: Ecosystem Development - The industrial park has cultivated a diverse ecosystem with 55 national high-tech enterprises and 6 national specialized "little giant" companies, fostering a collaborative environment for innovation [4] - By October 2025, the park is expected to attract over 290 enterprises, with a focus on medical devices, consumables, in vitro diagnostics, and medical software [4] Group 5: Future Outlook - The Hunan Medical Device Industrial Park aims to further enhance its development through reform and innovation, targeting an annual output value of 20 billion yuan, tax revenue of 1 billion yuan, and the creation of 8,000 jobs by the end of the 14th Five-Year Plan [5]
“湘”当能“械” 体制创新驱动 湘潭医疗器械产业蝶变
Core Insights - Hunan Xiangtan is transforming from a traditional Chinese medicine distribution center to a leading hub for medical device innovation in China, with a projected total output value exceeding 13 billion yuan by 2024 [1] Group 1: Industry Development - The Hunan Medical Device Industrial Park has been recognized as a national benchmark for medical device industrial parks for two consecutive years, showcasing effective integration of technological and industrial innovation [1] - The park has established a unique "4+N" service system that integrates government support with market efficiency, addressing common industry challenges such as slow approval processes and intellectual property conversion difficulties [2] Group 2: Approval Process Innovation - The establishment of the Hunan Provincial Drug Supervision Administration's Xiangtan branch has significantly improved the efficiency of product registration and approval, allowing companies to bring products to market faster [2] - For instance, Hunan Deps Medical Technology Co., Ltd. received its registration certificate in just one month, compared to the typical six-month timeframe for medical device production licenses [2] Group 3: Corporate Innovation - The Hunan Medical Device Industrial Park has developed a comprehensive industrial ecosystem that supports companies through all stages, from concept validation to clinical trials and logistics [3] - Companies like Huaxin Medical are gaining a foothold in the global market, with their products being exported to over 160 countries, demonstrating the park's capacity for fostering innovation [3] Group 4: Ecosystem and Cluster Development - The industrial park has cultivated a diverse ecosystem, with 55 national high-tech enterprises and 6 national specialized "little giant" companies, indicating a robust industrial cluster [4] - By October 2025, the park is expected to host over 290 enterprises, with a focus on medical devices, consumables, in vitro diagnostics, medical aesthetics, and software [5]
体制创新驱动湘潭医疗器械产业蝶变
Core Insights - Hunan Xiangtan is transforming from a traditional Chinese medicine distribution center to a leading hub for medical device innovation in China, with a projected total output value exceeding 13 billion yuan by 2024 [1][4] - The Hunan Medical Device Industrial Park has been recognized as a national benchmark for medical device industrial parks for two consecutive years, showcasing successful integration of technological and industrial innovation [1][4] Group 1: Approval and Efficiency - The establishment of the Hunan Provincial Drug Administration's Xiangtan branch has significantly improved the efficiency of medical device registration, allowing companies to expedite their product launches [2] - For instance, Hunan Deps Medical Technology Co., Ltd. received its registration certificate in just one month, compared to the typical six months for production licenses and even longer for product registration [2] Group 2: Enterprise Innovation and Global Market - The Hunan Medical Device Industrial Park focuses on meeting enterprise needs, creating a comprehensive industrial ecosystem that includes concept validation, clinical trials, and logistics [2] - Companies like Huaxin Medical are gaining a foothold in the global market, with their disposable bronchoscopes being exported to over 160 countries and achieving a leading market share [3] Group 3: Industrial Ecosystem and Growth - The park has developed a diverse industrial ecosystem characterized by leading enterprises and numerous small and medium-sized companies, with 55 national high-tech enterprises and 6 national specialized "little giant" companies nurtured within the park [3][4] - By the end of October 2025, the park aims to attract over 290 enterprises, with a focus on medical devices, consumables, in vitro diagnostics, and medical software, contributing to a projected annual output value of 20 billion yuan and tax revenue of 1 billion yuan [4]